The c-Fos results are not without precedent considering the actions of other peptide-based integrin antagonists (flavoridin) in melanoma cell lines, which increase activation of downstream integrin pathway elements (such as increased FAK phosphorylation) while also effecting downregulation c-Fos expression [47]. Here, FOS is linked to melanoma.